Bg pattern

BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PATIENT INFORMATION LEAFLET

BISOLVON MUCOLYTIC INFANT 0.8 MG/ML SYRUP

Bromhexine hydrochloride

Read the entire leaflet carefully before starting to take this medicine, as it contains important information for you.

Follow the administration instructions for the medicine contained in this leaflet or as indicated by your doctor or pharmacist exactly.

  • Keep this leaflet, as you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.
  • You should consult a doctor if your condition worsens or does not improve after 5 days of treatment.

Contents of the leaflet

  1. What BISOLVON MUCOLYTIC INFANT is and what it is used for
  2. What you need to know before taking BISOLVON MUCOLYTIC INFANT
  3. How to take BISOLVON MUCOLYTIC INFANT
  4. Possible side effects
  5. Storage of BISOLVON MUCOLYTIC INFANT
  6. Package contents and additional information

1. What BISOLVON MUCOLYTIC INFANT is and what it is used for

Bromhexine, the active ingredient of this medicine, belongs to the so-called mucolytics that act by decreasing the viscosity of mucous secretions, fluidizing them and facilitating their elimination.

This medicine is indicated to reduce the viscosity of mucus and phlegm, facilitating their expulsion, in colds and flu for children from 2 to 12 years old.

You should consult a doctor if your condition worsens or does not improve after 5 days of treatment.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking BISOLVON MUCOLYTIC INFANT

During the first days of treatment, as the secretions become more fluid, you may observe an increase in mucus and phlegm, which will decrease throughout the treatment.

Do not take BISOLVON MUCOLYTIC INFANT:

  • if you are allergic to bromhexine or any of the other components of this medicine (listed in section 6).
  • Children under 2 years of age cannot take this medicine.

Warnings and precautions

There have been reports of severe skin reactions associated with the administration of bromhexine hydrochloride. If you experience a skin rash (including lesions of the mucous membranes, such as the mouth, throat, nose, eyes, and genitals), stop using BISOLVON MUCOLYTIC and consult your doctor immediately.

You should consult your doctor before taking this medicine if you have:

  • Severe liver disease
  • Severe kidney disease
  • If you are asthmatic or have a history of asthma, suffer from any severe respiratory disease or have difficulty coughing
  • If you have diseases that predispose you to suffer from digestive bleeding, such as stomach or duodenal ulcers.

Children

Children under 2 yearsof age cannot take this medicine; it is contraindicated in them.

In children from 2 to 6 years old, it should be taken under medical supervision.

Other medicines and BISOLVON MUCOLYTIC INFANT

Taking Bisolvon Mucolytic Infant with other medicines

Tell your doctor or pharmacist if you are using, have recently used, or may need to use any other medicine.

Do not administer concurrently with antitussive medicines (for cough), as it may cause an accumulation of fluidized mucus, or with those that decrease bronchial secretions because they may counteract the effects of bromhexine. No negative interactions have been reported with antibiotics.

Taking BISOLVON MUCOLYTIC INFANT with food and drinks

Taking this medicine with food and drinks does not affect the efficacy of the treatment.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

No studies have been conducted on the effects of Bisolvon Mucolytic Infant on human fertility.

This medicine should not be used during pregnancy or breastfeeding.

Driving and using machines

During treatment with this medicine, dizziness may occur on some occasions; if you feel dizzy, do not drive or operate machines.

BISOLVON MUCOLYTIC INFANT contains Maltitol liquid

This medicine contains maltitol liquid. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medicine.

BISOLVON MUCOLYTIC INFANT contains benzoic acid

This medicine contains 1.27 mg of benzoic acid per ml. Benzoic acid may increase the risk of jaundice (yellowing of the skin and eyes) in newborns (up to 4 weeks old).

BISOLVON MUCOLYTIC INFANT contains propylene glycol

This medicine contains 4.725 mg of propylene glycol per ml. If the baby is less than 4 weeks old, consult your doctor or pharmacist, especially if the baby has been given other medicines that contain propylene glycol or alcohol.

3. How to take BISOLVON MUCOLYTIC INFANT

Follow the administration instructions for the medicine contained in this leaflet or as indicated by your doctor or pharmacist exactly. In case of doubt, ask your doctor or pharmacist.

The recommended dose is:

Children from 6 to 12 years old: 5 ml per dose, 3 times a day. Do not exceed the dose of 15 ml per day.

Children from 2 to 6 years old: 2.5 ml per dose, 3 times a day. Do not exceed the dose of 7.5 ml per day. In this population, consult your doctor before taking this medicine.

Children under 2 years old: Bisolvon Mucolytic Infant is contraindicated in children under 2 years old.

For adolescents over 12 years old, other pharmaceutical forms more suitable for this age group are available.

How to take:

This medicine is taken orally.

Measure the dose with the dosing cup included.

It is recommended to drink a glass of water or any other liquid after each dose and to drink plenty of liquid throughout the day.

If you worsen, symptoms persist, or new ones appear after 5 daysof treatment, or if you experience:

fever, skin rashes, persistent headache, or sore throat, consult your doctor.

Pre-filled syringe with clear liquid and silver needle ready for injection

If you take more BISOLVON MUCOLYTIC INFANT than you should

If you have taken more BISOLVON MUCOLYTIC INFANT than you should, you may experience vomiting, diarrhea, nausea, and abdominal pain. Consult your doctor or pharmacist immediately, or call the Toxicology Information Service, phone: 915.620.420, indicating the medicine and the amount taken.

If you forget to take BISOLVON MUCOLYTIC INFANT

Do not take a double dose to make up for forgotten doses.

If you have any other doubts about the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.

Uncommon side effects that may affect up to 1 in 100 people: vomiting, diarrhea, nausea, pain in the upper abdomen.

Rare side effects (may affect 1 in 1,000 people):

  1. Hypersensitivity reactions
  1. Bronchospasm (closure of airways in the lungs) or exanthema, urticaria.

Frequency not known (cannot be estimated from the available data):

  • Anaphylactic reactions, such as anaphylactic shock, angioedema (rapidly progressing swelling of the skin, subcutaneous tissues, mucous membranes, or submucosal tissues), and pruritus.
  • Dizziness and headache
  • Heartburn
  • Increased levels of transaminases (liver enzymes)
  • Severe cutaneous adverse reactions (such as erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis, and acute generalized exanthematous pustulosis).

Reporting side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of BISOLVON MUCOLYTIC INFANT

No special storage conditions are required.

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date stated on the packaging after EXP. The expiration date is the last day of the month indicated.

Do not use this medicine after 6 months of opening the packaging for the first time.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package contents and additional information

Composition of BISOLVON MUCOLYTIC INFANT

  • Each ml of syrup contains 0.8 milligrams of bromhexine hydrochloride.
  • The other components (excipients) are maltitol liquid (E-965), sucralose, benzoic acid (E-210), hydroxyethylcellulose, strawberry flavor, cherry flavor, and purified water.

Appearance of the product and package contents

BISOLVON MUCOLYTIC INFANT is a colorless or almost colorless syrup with a strawberry flavor.

It is presented in a glass bottle containing 100 ml of syrup and includes a dosing cup with graduations.

Marketing authorization holder and manufacturer

Marketing authorization holder

Opella Healthcare Spain, S.L.

C/ Rosselló i Porcel, 21

08016 – Barcelona

Spain

Sanofi Group

Manufacturer

Delpharm Reims S.A.S.

10 rue Colonel Charbonneaux

51100 Reims

France

Date of the last revision of this leaflet:August 2021

Additional information for the patient

Some colds and flu can be accompanied by an accumulation of mucus in the respiratory tract. On occasion, this mucus becomes thick and adheres to the walls of these airways.

This explains that in these processes, coughing occurs as a defense mechanism of the body itself against the appearance of mucosity, to expel phlegm and clear the airways.

Bromhexine fluidizes the adhered mucus, detaching it. At the end of the cold or flu, there is a decrease in mucosity and, therefore, in the cough needed to eliminate it.

Detailed information about this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP

Discuss questions about BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques. For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance. Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults. In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions. Patients commonly seek his care for: 

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns

Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.

Camera Book a video appointment
€80
5.0 (25)
Doctor

Lina Travkina

Family medicine 13 years exp.

Dr. Lina Travkina is a licensed family and preventive medicine doctor based in Italy. She provides online consultations for adults and children, supporting patients across all stages of care – from acute symptom management to long-term health monitoring and prevention.

Areas of medical care include:

  • Respiratory conditions: colds, flu, acute and chronic bronchitis, mild to moderate pneumonia, bronchial asthma.
  • ENT and eye conditions: sinusitis, tonsillitis, pharyngitis, otitis, infectious and allergic conjunctivitis.
  • Digestive issues: gastritis, acid reflux (GERD), IBS, dyspepsia, bloating, constipation, diarrhoea, functional bowel symptoms, intestinal infections.
  • Urological and infectious diseases: acute and recurrent cystitis, bladder and kidney infections, prevention of recurrent UTIs, asymptomatic bacteriuria.
  • Chronic conditions: hypertension, diabetes, hypercholesterolemia, metabolic syndrome, thyroid disorders, excess weight.
  • Neurological and general symptoms: headache, migraine, dizziness, fatigue, sleep disturbances, reduced concentration, anxiety, asthenia.
  • Chronic pain support: back, neck, joint, and muscle pain, tension syndromes, pain associated with osteochondrosis and chronic conditions.

Additional care areas:

  • Preventive consultations and check-up planning.
  • Medical advice and follow-up consultations.
  • Test interpretation and diagnostic guidance.
  • Structured support for undiagnosed complaints.
  • Second opinion on diagnoses and treatment plans.
  • Nutritional and lifestyle support for vitamin deficiencies, anaemia, metabolic issues.
  • Post-operative recovery support and pain management.
  • Preconception counselling and postpartum support.
  • Immunity support and strategies to reduce frequency of infections.

Dr. Travkina combines evidence-based medicine with an attentive, personalised approach. Her consultations focus not only on treatment, but also on prevention, recovery, and long-term wellbeing.

If during the consultation it becomes clear that your case requires in-person assessment or specialised care outside of her scope, the session will be terminated and the payment fully refunded.

Camera Book a video appointment
€70
5.0 (766)
Doctor

Alina Tsurkan

Family medicine 13 years exp.

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including:

  • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs.
  • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis.
  • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation.
  • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea.
  • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections.
  • Chronic diseases: hypertension, elevated cholesterol, weight management.
  • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness.
  • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance.

She also provides:

  • IMT medical certificates for driving licence exchange in Portugal.
  • Personalised preventive care and wellness consultations.
  • Interpretation of test results and medical reports.
  • Follow-up care and medication review.
  • Support in managing multiple coexisting conditions.
  • Remote prescription management and medical documentation.

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

Camera Book a video appointment
€55
5.0 (140)
Doctor

Yevgen Yakovenko

General surgery 12 years exp.

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

Camera Book a video appointment
€50

Frequently Asked Questions

Is a prescription required for BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP?
BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP?
The active ingredient in BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP is bromhexine. This information helps identify medicines with the same composition but different brand names.
Who manufactures BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP?
BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP is manufactured by Opella Healthcare Spain S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to BISOLVON MUCOLITIC INFANTILE 0.8 mg/ml SYRUP?
Other medicines with the same active substance (bromhexine) include BISOLVON MUCOLITIC 1.6 mg/ml SYRUP, ACETYLCYSTEINE ABEX 600 mg EFFERVSCENT TABLETS, ACETYLCYSTEINE ALTER 600 mg EFFERVSCENT TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media